Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Research has demonstrated that metabolic disease models are frequently associated with altered NAD+ metabolism, with studies showing reduced NAD+ levels in animal models of type 2 diabetes, obesity, and metabolic syndrome
Most Frequently Reported Effects Subcutaneous peptide injections most commonly produce mild local effects: redness, mild swelling, or sensitivity at the injection site
AOD-9604 plus growth hormone secretagogues Combining AOD-9604 with growth hormone secretagogues like CJC-1295/Ipamorelin creates a synergistic approach to body composition
Each plays a different role in your body
Unlike prescription medications that may alter appetite or nutrient absorption, and require close medical supervision due to potential side effects, lipotropic injections are generally well-tolerated
History AOD-9604 was developed following research identifying the amino acid sequence 176-191 of human growth hormone as a region associated with specific metabolic activities
